statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gracell Biotechnologies (NASDAQ:GRCL) Earns "Hold" Rating from Stifel Nicolaus

Stifel Nicolaus restated their hold rating on shares of Gracell Biotechnologies (NASDAQ:GRCL  Free Report) in a report released on Thursday morning, Benzinga reports. Stifel Nicolaus currently...

Gracell Biotechnologies Acquisition Completed

SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ( Gracell or the Company , Nasdaq: GRCL), a global clinical-stage biopharmaceutical...

Gracell Biotechnologies Sees Unusually High Options Volume (NASDAQ:GRCL)

Gracell Biotechnologies Inc. (NASDAQ:GRCL  Get Free Report) saw unusually large options trading activity on Tuesday. Stock traders purchased 13,143 put options on the company. This is an...

AstraZeneca Deal For Gracell Biotechnologies Closing Tomorrow (Includes CVR)

AstraZeneca Deal For Gracell Biotechnologies Closing Tomorrow (Includes CVR...

Gracell Biotechnologies Announces Shareholders' Approval of Merger Agreement

SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ( Gracell or the Company , NASDAQ: GRCL), a global clinical-stage biopharmaceutical...

Gracell Biotechnologies (NASDAQ:GRCL) Sets New 12-Month High at $10.36

Shares of Gracell Biotechnologies Inc. (NASDAQ:GRCL  Get Free Report) hit a new 52-week high during trading on Friday . The company traded as high as $10.36 and last traded at $10.36, with a...

Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma

Further expands clinical development of FasTCAR-T GC012F in multiple myeloma amid ongoing U.S. trial evaluating therapy for treatment of relapsed/refractory multiple myelomaSAN DIEGO and SUZHOU...

ALERT: The M&A Class Action Firm Continues Investigating the Merger   GRCL, AXNX, HARP, CVLY

NEW YORK, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the M&A Class Action Firm ), a national securities...

SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates PGTI, KRTX, THRX, GRCL

NEW YORK, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates AMAM, AXNX, HARP, GRCL

SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates AMAM, AXNX, HARP, GRCL SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates AMAM, AXNX, HARP, GRCL PR Newswire NEW YORK...

Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer. The company's therapy offers cellular therapeutics for the patients suffered from hematological malignancy, solid tumor or degenerative disease, enabling healthcare providers to cure their patients and improve their lives.

Volume	6.42M
52-Wk High	$10.44
52-Wk Low	$1.40

GRCL Gracell Biotechnologies Inc

About

Feed

News

Earnings

Fundamentals